Surveillance network for pediatric infectious diseases
Official title: Real Time Surveillance of Pediatric Infectious Diseases in French Ambulatory Care: PARI Study
Run by Association Clinique Thérapeutique Infantile du val de Marne · NCT04471493 · Data updated 2026-11-12
This study is trying to see if training pediatricians to use new testing tools and shared records can help them diagnose and treat infectious diseases in children better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Day to 16 Years |
| Sex | All |
| Enrollment | 400000 (estimated) |
| Sponsor | Association Clinique Thérapeutique Infantile du val de Marne Academic / other |
| Locations | 1 site (Créteil) |
| Status | Recruiting |
| Started | June 26, 2017 |
| Main results expected | June 27, 2030 |
| Study ends | August 2, 2030 |
| Registry record updated | February 8, 2024 |
| Trial ID | NCT04471493 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children under 16 years of age diagnosed with infectious diseases like otitis, influenza, or bronchiolitis.
✕Probably not a fit
Patients whose parents refuse participation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study establishes a surveillance network focused on pediatric infectious diseases by training pediatricians in the use of point of care tests and standardized electronic medical records. A total of 107 pediatricians from the French ambulatory pediatric association will participate, diagnosing conditions such as otitis, bronchiolitis, and influenza in children under 16. The network aims to enhance the accuracy of diagnoses and improve treatment protocols through automated data extraction and shared resources among practitioners.
Why it matters
Potential benefit: If successful, this initiative could lead to improved diagnosis and management of infectious diseases in children, enhancing overall pediatric care.
How similar studies have gone: Other studies have shown success in similar approaches to pediatric infectious disease management, indicating potential for positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children under 16 years of age with at least one infectious disease among: * pharyngitis * otitis * pneumonia * influenza * bronchiolitisz * varicella * gastroenteritis * enterovirus disease * bordetella pertussis disease * using the same same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France) Exclusion Criteria: * parental refusal
Where it's running
-
Afpa
Créteil, France Recruiting
Study contacts
- Study coordinator: Corinne LEVY, MD
- Email: corinne.levy@activ-france.fr
- Phone: 0033148850404
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimising Antibiotic Use for Paediatric LRTIs in Africa
This study tests whether using point-of-care CRP tests together with the PREPARE score can safely reduce antibiotic use in infants aged 2–24 months with lower respiratory infections in a Johannesburg hospital.
-
Effects of suctioning on pain and stress in intubated ICU patients
This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.
-
Comparing automatic vs. as-needed follow-up care for children after hospitalization
This study tests whether regular follow-up visits for kids after being in the hospital can help them stay healthy and avoid going back to the hospital, compared to only seeing a doctor when needed.
-
High-dose vs standard-dose flu vaccine in adults with blood cancers on B-cell-depleting therapy
This study tests whether a high-dose flu shot evokes a stronger immune response than a standard-dose shot in adults with hematologic cancers who recently had B-cell-depleting therapy.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
AI-powered CT help to guide pneumonia care
A multicenter trial tests whether using a chest CT–based AI report to guide care reduces death or need for new organ support in adults with pneumonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.